Particulars |
Company Name |
Oxygenta Pharmaceutical Ltd |
Year End |
2023/03 |
Full Year |
Equity (Rs Cr.) |
33.48 |
B.V (Rs) |
-7.50 |
Sales (Rs Cr.) |
30.99 |
NP. (Rs Cr.) |
-10.85 |
NP Var% |
-948.00 |
Div% |
0.00 |
CPS (Rs) |
-2.60 |
EPS (Rs) |
-3.20 |
Traded Value (Rs Lakhs) |
0.68 |
52 Week High |
52.00 |
52 Week Low |
25.00 |
Price BSE |
37.00 |
Price NSE |
0.00 |
Market Capital (Rs Cr.) |
123.89 |
P/C Ratio |
-14.10 |
P/E Ratio |
-11.40 |
Price Vs.BV |
-4.93 |
|
Latest Quarter |
Year End |
202312 |
Sales (Rs Cr.) |
9.15 |
NP (Rs Cr.) |
-3.73 |
NP Var % |
-28.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
37.96 |
OPM |
-8.46 |
NP |
-5.39 |
NP Var% |
-81.02 |
EPS |
0.00 |
PE |
0.00 |
|
|